Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast CancerMAUNSELL, Elizabeth; GOSS, Paul E; HENDRIX, Susan et al.Journal of clinical oncology. 2014, Vol 32, Num 14, pp 1427-1436, issn 0732-183X, 10 p.Article

Exemestane for Breast-Cancer Prevention in Postmenopausal WomenGOSS, Paul E; INGLE, James N; WINQUIST, Eric et al.The New England journal of medicine. 2011, Vol 364, Num 25, pp 2381-2391, issn 0028-4793, 11 p.Article

Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort studyPASTOR-BARRIUSO, Roberto; ASCUNCE, Nieves; EDERRA, María et al.Breast cancer research and treatment. 2013, Vol 138, Num 1, pp 249-259, issn 0167-6806, 11 p.Article

Exemestane Versus Anastrozole as Front-Line Endocrine Therapy in Postmenopausal Patients With Hormone Receptor-Positive, Advanced Breast Cancer: Final Results from the Spanish Breast Cancer Group 2001-03 Phase 2 Randomized TrialLLOMBART-CUSSAC, Antonio; RUIZ, Amparo; CARRASCO, Eva et al.Cancer. 2012, Vol 118, Num 1, pp 241-247, issn 0008-543X, 7 p.Article